Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...

Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.

Ireland's pharmaceutical industry shipped billions' worth of goods to the U.S., but face threats from Trump 2.0.

The new weight loss drug offers promising results for those who are overweight or obese. Learn about how Zepbound works, its ...

For years, conventional wisdom has been that weight loss is a matter of willpower. Those who are overweight or obese just need to try harder to eat less and exercise more. But while diet and ...

Eli Lilly’s launch of GLP-1 weight loss medication Zepbound, which it produces from a Cork site, could well explain much of the drastic €18.6 billion ($19.4 billion) increase in Irish goods ...

The company created its GLP-1 Insurance Checker specifically to help you determine your coverage on popular weight loss drugs like Ozempic, Wegovy, and Zepbound. If you're new to Ro, they'll even ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're about to lose access. Health 2025-01-22T08:18:01Z A woman regained weight ...

Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound surged in the fourth quarter despite missing the company’s initial sales expectations. Zepbound sales reached $1.9 billion in ...

its lack of subscription fees and its handy smartphone app with a chat feature for patients to talk to one another during their weight-loss journeys. The Zappy chat was ultimately how many ...

open image in gallery A small percentage of patients taking weight loss and diabetes drugs like Ozempic and Zepbound have experienced vision loss. However, scientists they there is not an ...